These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 27340132)

  • 21. Fibril formation and toxicity of the non-amyloidogenic rat amylin peptide.
    Milton NG; Harris JR
    Micron; 2013 Jan; 44():246-53. PubMed ID: 22854213
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of copper(II) in the aggregation of human amylin.
    Sinopoli A; Magrì A; Milardi D; Pappalardo M; Pucci P; Flagiello A; Titman JJ; Nicoletti VG; Caruso G; Pappalardo G; Grasso G
    Metallomics; 2014 Oct; 6(10):1841-52. PubMed ID: 25080969
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oxidant-modified amylin fibrils and aggregates alter the inflammatory profile of multiple myeloid cell types, but are non-toxic to islet β cells.
    Clemen R; Fuentes-Lemus E; Bekeschus S; Davies MJ
    Redox Biol; 2023 Sep; 65():102835. PubMed ID: 37544243
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amylin: Pharmacology, Physiology, and Clinical Potential.
    Hay DL; Chen S; Lutz TA; Parkes DG; Roth JD
    Pharmacol Rev; 2015 Jul; 67(3):564-600. PubMed ID: 26071095
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Feasibility of amylin imaging in pancreatic islets with β-amyloid imaging probes.
    Yoshimura M; Ono M; Watanabe H; Kimura H; Saji H
    Sci Rep; 2014 Aug; 4():6155. PubMed ID: 25142178
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An insulin-degrading enzyme inhibitor decreases amylin degradation, increases amylin-induced cytotoxicity, and increases amyloid formation in insulinoma cell cultures.
    Bennett RG; Hamel FG; Duckworth WC
    Diabetes; 2003 Sep; 52(9):2315-20. PubMed ID: 12941771
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hyperamylinemia Increases IL-1β Synthesis in the Heart via Peroxidative Sarcolemmal Injury.
    Liu M; Verma N; Peng X; Srodulski S; Morris A; Chow M; Hersh LB; Chen J; Zhu H; Netea MG; Margulies KB; Despa S; Despa F
    Diabetes; 2016 Sep; 65(9):2772-83. PubMed ID: 27335231
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Causative factors for formation of toxic islet amyloid polypeptide oligomer in type 2 diabetes mellitus.
    Jeong HR; An SS
    Clin Interv Aging; 2015; 10():1873-9. PubMed ID: 26604727
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased toxicity of amylin (Islet Amyloid Polypeptide) in beta cells induced by photochemical internalization.
    Rinku S; Hals I; Høgset A; Grill V; Gederaas OA
    Photodiagnosis Photodyn Ther; 2018 Sep; 23():218-220. PubMed ID: 29936141
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of human amylin aggregation by Flavonoid Chrysin: An
    Alkahtane AA; Alghamdi HA; Almutairi B; Khan MM; Hasnain MS; Abdel-Daim MM; Alghamdi WM; Alkahtani S
    Int J Med Sci; 2021; 18(1):199-206. PubMed ID: 33390788
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Butyrylcholinesterase interactions with amylin may protect pancreatic cells in metabolic syndrome.
    Shenhar-Tsarfaty S; Bruck T; Bennett ER; Bravman T; Aassayag EB; Waiskopf N; Rogowski O; Bornstein N; Berliner S; Soreq H
    J Cell Mol Med; 2011 Aug; 15(8):1747-56. PubMed ID: 20807286
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amylin brain circuitry.
    Boccia L; Gamakharia S; Coester B; Whiting L; Lutz TA; Le Foll C
    Peptides; 2020 Oct; 132():170366. PubMed ID: 32634450
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Creating the amylin story.
    Lutz TA
    Appetite; 2022 May; 172():105965. PubMed ID: 35183619
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pomegranate peel, chokeberry leaves and Ironwort extract as novel natural inhibitors of amylin aggregation and cellular toxicity in pancreatic β cells.
    Rishisree A; Mallory B; Elena K; Teodora J; Gordana Z; Katarina Š; Aleksandar J
    Biophys Chem; 2024 Jan; 304():107130. PubMed ID: 37952497
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus.
    Lorenzo A; Razzaboni B; Weir GC; Yankner BA
    Nature; 1994 Apr; 368(6473):756-60. PubMed ID: 8152488
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of Ca2+ in apoptosis evoked by human amylin in pancreatic islet beta-cells.
    Bai JZ; Saafi EL; Zhang S; Cooper GJ
    Biochem J; 1999 Oct; 343 Pt 1(Pt 1):53-61. PubMed ID: 10493911
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel radiogallium-labeled pyridyl benzofuran derivative for detection of amylin aggregates in pancreas.
    Watanabe H; Kawano K; Iikuni S; Shimizu Y; Ono M
    Nucl Med Biol; 2020; 90-91():93-97. PubMed ID: 33189949
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hyperamylinemia as a risk factor for accelerated cognitive decline in diabetes.
    Ly H; Despa F
    Expert Rev Proteomics; 2015; 12(6):575-7. PubMed ID: 26503000
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of proteolytically stable N-methylated peptide inhibitors of aggregation of the amylin peptide implicated in type 2 diabetes.
    Obasse I; Taylor M; Fullwood NJ; Allsop D
    Interface Focus; 2017 Dec; 7(6):20160127. PubMed ID: 29147551
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assay development and multivariate scoring for high-content discovery of chemoprotectants of endoplasmic-reticulum-stress-mediated amylin-induced cytotoxicity in pancreatic beta cells.
    Law CJ; Ashcroft HA; Zheng W; Sexton JZ
    Assay Drug Dev Technol; 2014 Sep; 12(7):375-84. PubMed ID: 25181410
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.